NCT00517101Unknown不适用
Presence of IBD Specific Antibodies (ASCA, ALCA, ACCA, AMCA) in the Sera of Patients With Spondyloarthropathy
适应症
试验速览
- 阶段
- 不适用
研究概览
简要总结
A relationship between IBD and spondyloarthropathy is well recognized. ASCA ( anti saccharomyces cerevisiae antibodies)are considered to be a serological marker for Crohn's disease and have been studied in patients with spondyloarthropathy with conflicting results. More recently, new serological markers for IBD have been described. These markers are antibodies to certain defined glycans , and their use may permit an improved diagnosis of IBD.
The aim of our study is to investigate wether these new serological markers are present in the sera of patients with spondyloarthropathy.
研究设计
- 研究类型
- Observational
- 观察模型
- Defined Population
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •diagnosis of psoriatic arthritis, ankylosing spondylitis, or undifferentiated spondyloarthropathy
排除标准
- •diagnosed inflammatory bowel disease
研究者
相似试验
Unknown
不适用
Rheumatological Manifestations in Inflammatory Bowel DiseasesInflammatory Bowel DiseasesNCT03486652Assiut University70
招募中
不适用
axSEND: Exploring Immune and Microbiota Effects of a Partial Enteral Nutrition Diet in Axial SpondyloarthritisAxial SpondyloarthritisInflammationDysbiosisArthritisSpondylitisAxSpASpAAnkylosing SpondylitisSpondylarthritisNCT06460805NHS Greater Glasgow and Clyde62
招募中
不适用
Analysis of Intestinal Microbiota as a Predictor of Response to Treatment of Spondyloarthritis With BiotherapySpondyloarthritisNCT04899154Hôpital Européen Marseille80
尚未招募
不适用
Prevelance of Axial Spondylosis Arthritis in Inflammatory Bowel Disease and Its RESPONSE to Tumour Necrosis Factor (TNF) Inhibitors Treatment in Assiut University HospitalInflammatory Bowel Disease (IBD)SpondylarthropathiesTNF-alpha InhibitorsNCT06601595Mohamed Nasr100
已完成
不适用
A study to investigate how common a diagnosis of axial spondyloarthritis (axSpA) is in patients with known inflammatory bowel disease (IBD) such as Crohn’s Disease and Ulcerative Colitis, and the development of a tool to direct referral of patients with suspected axSpA in IBD patients to a rheumatology specialist.ISRCTN30265575orfolk and Norwich University Hospitals NHS Foundation Trust470